⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

PLSE

Pulse Biosciences, Inc.

Healthcare · Medical Instruments & Supplies

53.02USD

+0.3400 (+0.65%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on PLSE.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 53.02
P/E—
Dvd Ind Yld0.0%
P/B38.01
P/S3,191.2
Curr EV/T12M EBITDA-44.6
Mkt Cap (USD)3.8B
Curr EV (USD)3.7B
2)

Per Share Data

EPS T12M-1.18
DPS—
Bk Val Per Sh1.41
Rev/Sh0.03
Cash/Sh1.43
Curr Shares Out71.3M
FCF/Sh-1.65
3)

Cash Flow Analysis

P/CF-61.9
Curr P/FCF-61.6
CF/NI0.8
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-5155.9%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr-17.4%
Cap 1Y Gr-29.8%
BPS 1Y Gr—
R&D To Sales4378.6%
Retention Rate—
Rev 1Y Gr—
FCF 1Y Gr-49.3%
Assets 1Y Gr-28.6%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-7007.8%
Pretax Margin3304.4%
Net Margin-6755.8%
ROA-67.9%
ROE-78.5%
ROC-78.1%
Asset Turnover0.01
6)

Structure

Current Ratio9.63
Quick Ratio9.27
Debt/Assets5.9%
Debt/Com Eq6.8%
Net Debt/EBITDA1.15
Tot Debt/Capital6.4%
Gross Margin0.3%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.